About
Intracellular delivery is the most problematic step in T cell immunotherapy discovery, development and manufacturing. Indee Labs is developing a non-viral intracellular delivery system based on microfluidic vortex shedding (µVS) to rapidly deliver nucleic acids, proteins and gene editing complexes to patient and donor T cells with minimal perturbation.
Healthcare & Life Sciences
Looking for
Talent to hirePartners & collaboratorsFunding
Founders and key people
Highlights
Highlights coming soon
Notable work and milestones will show up here.

